Patent · US Active

Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group

US11508483B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

Adverio Pharma GmbH · DE

Inventors

Peter Sandner · Wuppertal, DE
Melanie Hemmrich · Düsseldorf, DE
Janethe de Oliveira Pena · Kendall Park, US
Stephen Dawe · Harrowby, GB

Key dates

Filing date	May 28, 2019
Grant date	Nov 22, 2022
Priority date	—
Expiry date	Sep 22, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method of identifying a subgroup of patients suffering from diffuse cutaneous systemic sclerosis (dcSSc) which subgroup of patients benefits from a treatment with at least one sGC stimulator and/or sGC activator in a higher degree than patients not belonging to this subgroup.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.